JNJ — Johnson & Johnson Balance Sheet
0.000.00%
- $498.53bn
- $525.76bn
- $88.82bn
- 91
- 39
- 94
- 89
Annual balance sheet for Johnson & Johnson, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2021 January 3rd | 2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 25,185 | 31,608 | 22,927 | 23,519 | 24,522 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13,576 | 15,283 | 14,873 | 16,160 | 14,842 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 51,237 | 60,979 | 53,495 | 55,294 | 55,893 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 19,766 | 19,862 | 20,898 | 20,903 | 21,618 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 174,894 | 182,018 | 167,558 | 187,378 | 180,104 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 42,493 | 45,226 | 46,282 | 55,802 | 50,321 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 111,616 | 107,995 | 98,784 | 110,574 | 108,614 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 63,278 | 74,023 | 68,774 | 76,804 | 71,490 |
| Total Liabilities & Shareholders' Equity | 174,894 | 182,018 | 167,558 | 187,378 | 180,104 |
| Total Common Shares Outstanding |